Highlight selection of radiochemistry and radiopharmacy developments by editorial board

Toyohara, Jun; Al‐Qahtani, Mohammed; Huang, Ya-Yao; Cazzola, Emiliano; Todde, Sergio; Furumoto, Shozo; Mikołajczak, Renata; Decristoforo, Clemens; Gillings, Nic; Yang, Min; Reilly, Raymond M.; Duatti, Adriano; Denkova, Antonia G.; Schirrmacher, Ralf; Carlucci, Giuseppe; Seimbille, Yann; Liu, Zhaofei; Ellis, B. L.; Cornelissen, Bart T; Kopka, Klaus; Bernardes, Emerson Soares

doi:10.1186/s41181-022-00177-w

Cited by 2 publications

(1 citation statement)

References 36 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Due to this attractive expression pattern, anti-FAP radiopharmaceuticals have been a hot topic for diagnostic and therapeutic applications. Several anti-FAP small molecule-based, for example OncoFAP [12], FAPI-04 [13,14], FAPI-46 [15], FAPI-74 [16] and PNT6555 [17] and peptide-based radiopharmaceuticals, such as FAP-2286 [18], have been developed in recent years and are currently being tested in the clinic [19][20][21][22].…”

Section: Introductionmentioning

confidence: 99%

Generic semi-automated radiofluorination strategy for single domain antibodies: [18F]FB-labelled single domain antibodies for PET imaging of Fibroblast Activation Protein-α or Folate Receptor-α overexpression in cancer

Dierick,

Navarro,

Ceuppens

et al. 2024

Preprint

View full text Add to dashboard Cite

Background Radiofluorination of single domain antibodies (sdAbs) via N-succinimidyl-4-[18F]fluorobenzoate ([18F]SFB) has shown to be a promising strategy in the development of sdAb-based PET tracers. While automation of the prosthetic group (PG) has been successfully reported, no practical method for large scale sdAb labelling has been reported. Therefore, we optimized and automated the PG production, enabling a subsequently efficient manual conjugation reaction to an anti-fibroblast activation protein (FAP)-α sdAb (4AH29) and an anti-folate receptor (FR)-α sdAb (1012). Both the alpha isoform of FAP and the FR are established tumour markers. FAP-α is known to be overexpressed mainly by cancer-associated fibroblasts in breast, ovarian, and other cancers, while its expression in normal tissues is low or undetectable. FR-α has an elevated expression in epithelial cancers, such as ovarian, brain and lung cancers. Non-invasive imaging techniques, such as PET-imaging, can provide a detailed picture of the characteristics of both the tumour and its environment, which is critical for the success of cancer treatments. Results [18F]SFB was synthesized using a fully automated three-step, one-pot reaction. The total procedure time was 54 minutes and results in [18F]SFB with a RCP > 90% and a RCY d.c. of 44 ± 4% (n = 13). The conjugation reaction after purification produced [18F]FB-sdAbs with a RCP > 95%, an end of synthesis activity > 600 MBq and an apparent molar activity > 10 GBq/µmol. Overall RCY d.c. were 9% and 5 ± 2% (n = 3) for [18F]FB-1012 and [18F]FB-4AH29, respectively. Conclusion [18F]SFB synthesis was successfully automated and upscaled on a Trasis AllInOne module. The anti-hFAP-α and anti-hFR-α sdAbs were radiofluorinated, yielding similar RCYs d.c. and RCPs, showing the potential of this method as a generic radiofluorination strategy for sdAbs. The radiofluorinated sdAbs showed a favourable biodistribution pattern and are attractive for further characterization as new PET tracers for FAP-α and FR-α imaging.

show abstract

Section: Introductionmentioning

confidence: 99%

Generic semi-automated radiofluorination strategy for single domain antibodies: [18F]FB-labelled single domain antibodies for PET imaging of Fibroblast Activation Protein-α or Folate Receptor-α overexpression in cancer

Dierick,

Navarro,

Ceuppens

et al. 2024

Preprint

View full text Add to dashboard Cite

show abstract

Generic semi-automated radiofluorination strategy for single domain antibodies: [18F]FB-labelled single domain antibodies for PET imaging of fibroblast activation protein-α or folate receptor-α overexpression in cancer

Dierick,

Navarro,

Ceuppens

et al. 2024

EJNMMI radiopharm. chem.

View full text Add to dashboard Cite

Background Radiofluorination of single domain antibodies (sdAbs) via N-succinimidyl-4-[18F]fluorobenzoate ([18F]SFB) has shown to be a promising strategy in the development of sdAb-based PET tracers. While automation of the prosthetic group (PG) [18F]SFB production, has been successfully reported, no practical method for large scale sdAb labelling has been reported. Therefore, we optimized and automated the PG production, enabling a subsequently efficient manual conjugation reaction to an anti-fibroblast activation protein (FAP)-α sdAb (4AH29) and an anti-folate receptor (FR)-α sdAb (2BD42). Both the alpha isoform of FAP and the FR are established tumour markers. FAP-α is known to be overexpressed mainly by cancer-associated fibroblasts in breast, ovarian, and other cancers, while its expression in normal tissues is low or undetectable. FR-α has an elevated expression in epithelial cancers, such as ovarian, brain and lung cancers. Non-invasive imaging techniques, such as PET-imaging, using tracers targeting specific tumour markers can provide molecular information over both the tumour and its environment, which aides in the diagnosis, therapy selection and assessment of the cancer treatment. Results [18F]SFB was synthesized using a fully automated three-step, one-pot reaction. The total procedure time was 54 min and results in [18F]SFB with a RCP > 90% and a RCY d.c. of 44 ± 4% (n = 13). The manual conjugation reaction after purification produced [18F]FB-sdAbs with a RCP > 95%, an end of synthesis activity > 600 MBq and an apparent molar activity > 10 GBq/µmol. Overall RCY d.c., corrected to the trapping of [18F]F− on the QMA, were 9% (n = 1) and 5 ± 2% (n = 3) for [18F]FB-2BD42 and [18F]FB-4AH29, respectively. Conclusion [18F]SFB synthesis was successfully automated and upscaled on a Trasis AllInOne module. The anti-hFAP-α and anti-hFR-α sdAbs were radiofluorinated, yielding similar RCYs d.c. and RCPs, showing the potential of this method as a generic radiofluorination strategy for sdAbs. The radiofluorinated sdAbs showed a favourable biodistribution pattern and are attractive for further characterization as new PET tracers for FAP-α and FR-α imaging.

show abstract

Highlight selection of radiochemistry and radiopharmacy developments by editorial board

Cited by 2 publications

References 36 publications

Generic semi-automated radiofluorination strategy for single domain antibodies: [18F]FB-labelled single domain antibodies for PET imaging of Fibroblast Activation Protein-α or Folate Receptor-α overexpression in cancer

Generic semi-automated radiofluorination strategy for single domain antibodies: [18F]FB-labelled single domain antibodies for PET imaging of Fibroblast Activation Protein-α or Folate Receptor-α overexpression in cancer

Generic semi-automated radiofluorination strategy for single domain antibodies: [18F]FB-labelled single domain antibodies for PET imaging of fibroblast activation protein-α or folate receptor-α overexpression in cancer

Contact Info

Product

Resources

About